Critical Path Resources available to advance candidates into Phase I trials.
back to top
Bulletin: HVTN 505 HIV Vaccine Study Begins Enrolling Volunteers—Aug. 24, 2009
Q&A: The HVTN 505 HIV Vaccine Regimen Study—Aug. 24, 2009